To the press room
Update 7:51am Pacific Time – Saturday, November 14, 2020
According to reports, antidepressants may help combat serious illnesses in coronavirus patients. According to reports on Friday, a clinical trial in St. Louis, Missouri, indicated that fluvoxamine may help prevent the deterioration of patients who have not yet been hospitalized.
The University of Washington School of Medicine tested 152 patients. Those who received the antidepressant did not see “clinical deterioration”, while the six patients who did not receive the drug did not.
Dr. Alban Gaultier of the Medical College of Virginia reported that the clinical trial showed significant results.
He explained: “Nevertheless, it is indeed very comforting. We need to repeat the study on more patients. This will be called a phase 3 clinical trial.” “And I think it will start soon.”
UVA researcher Dr. Alban Gaultier and his team used probiotics to reverse depression symptoms in mice https://t.co/X6MzSP5UH8
-UVA SOM Fac Dev (@UVaSOMFacDev) March 9, 2017
Dr. Gaudia compares antidepressants to ibuprofen for coronavirus, which is said to be a way for patients to monitor their condition early.